O’Melveny Worldwide

GlobeNewswire: Repligen Announces Agreement to Acquire Chromatography Innovator Tantti

July 29, 2024

O’Melveny advised Tantti Laboratory Inc., a biomaterials engineering company, on its agreement to be acquired by Repligen Corporation, a life sciences company focused on bioprocessing technology leadership.

Read the full article here.